A carregar...
Local, Controlled Release In Vivo of Vascular Endothelial Growth Factor Within a Subcutaneous Scaffolded Islet Implant Reduces Early Islet Necrosis and Improves Performance of the Graft
Islet transplantation remains the only alternative to daily insulin therapy for control of type 1 diabetes (T1D) in humans. To avoid the drawbacks of intrahepatic islet transplantation, we are developing a scaffolded islet implant to transplant islets into nonhepatic sites. The implant test bed, siz...
Na minha lista:
| Publicado no: | Cell Transplant |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6038045/ https://ncbi.nlm.nih.gov/pubmed/29756517 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0963689718754562 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|